Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 123

1.

Phase 2 clinical trial of TORC1 inhibition with everolimus in men with metastatic castration-resistant prostate cancer.

George DJ, Halabi S, Healy P, Jonasch D, Anand M, Rasmussen J, Wood SY, Spritzer C, Madden JF, Armstrong AJ.

Urol Oncol. 2019 Sep 12. pii: S1078-1439(19)30333-3. doi: 10.1016/j.urolonc.2019.08.015. [Epub ahead of print]

PMID:
31522863
2.

Low-Grade Papillary Schneiderian Carcinoma of the Sinonasal Cavity and Temporal Bone.

Brown CS, Abi Hachem R, Pendse A, Madden JF, Francis HW.

Ann Otol Rhinol Laryngol. 2018 Dec;127(12):974-977. doi: 10.1177/0003489418803391. Epub 2018 Sep 29.

PMID:
30269519
3.

Preliminary Efficacy Testing of the Disinfectant MicrobeCare XLP for Potential Use in Military Operational Environments.

Madden JF, Henrichs L, Ervin MD, Lospinoso J, Beachkofsky TM, Hardin CA.

Mil Med. 2018 Nov 1;183(11-12):e348-e353. doi: 10.1093/milmed/usy039.

PMID:
29635286
4.

Macrophage Epithelial Reprogramming Underlies Mycobacterial Granuloma Formation and Promotes Infection.

Cronan MR, Beerman RW, Rosenberg AF, Saelens JW, Johnson MG, Oehlers SH, Sisk DM, Jurcic Smith KL, Medvitz NA, Miller SE, Trinh LA, Fraser SE, Madden JF, Turner J, Stout JE, Lee S, Tobin DM.

Immunity. 2016 Oct 18;45(4):861-876. doi: 10.1016/j.immuni.2016.09.014.

5.

Can Radiologic Staging With Multiparametric MRI Enhance the Accuracy of the Partin Tables in Predicting Organ-Confined Prostate Cancer?

Gupta RT, Brown AF, Silverman RK, Tay KJ, Madden JF, George DJ, Polascik TJ.

AJR Am J Roentgenol. 2016 Jul;207(1):87-95. doi: 10.2214/AJR.15.15878. Epub 2016 Apr 11.

PMID:
27064383
6.

Apparent Diffusion Coefficient Values of the Benign Central Zone of the Prostate: Comparison With Low- and High-Grade Prostate Cancer.

Gupta RT, Kauffman CR, Garcia-Reyes K, Palmeri ML, Madden JF, Polascik TJ, Rosenkrantz AB.

AJR Am J Roentgenol. 2015 Aug;205(2):331-6. doi: 10.2214/AJR.14.14221.

7.

Functional heterogeneity of calretinin-expressing neurons in the mouse superficial dorsal horn: implications for spinal pain processing.

Smith KM, Boyle KA, Madden JF, Dickinson SA, Jobling P, Callister RJ, Hughes DI, Graham BA.

J Physiol. 2015 Oct 1;593(19):4319-39. doi: 10.1113/JP270855. Epub 2015 Aug 27.

8.

Evaluation of cold ischemia for preservation of testicular function during partial orchiectomy in the rat model.

McNamara ER, Madden-Fuentes RJ, Routh JC, Rouse D, Madden JF, Wiener JS, Rushton HG Jr, Ross SS.

J Pediatr Urol. 2014 Aug;10(4):593-7. doi: 10.1016/j.jpurol.2014.06.005. Epub 2014 Jul 10.

9.

Comparing 3-T multiparametric MRI and the Partin tables to predict organ-confined prostate cancer after radical prostatectomy.

Gupta RT, Faridi KF, Singh AA, Passoni NM, Garcia-Reyes K, Madden JF, Polascik TJ.

Urol Oncol. 2014 Nov;32(8):1292-9. doi: 10.1016/j.urolonc.2014.04.017. Epub 2014 May 23.

PMID:
24863013
10.

Improving the lens design and performance of a contemporary electromagnetic shock wave lithotripter.

Neisius A, Smith NB, Sankin G, Kuntz NJ, Madden JF, Fovargue DE, Mitran S, Lipkin ME, Simmons WN, Preminger GM, Zhong P.

Proc Natl Acad Sci U S A. 2014 Apr 1;111(13):E1167-75. doi: 10.1073/pnas.1319203111. Epub 2014 Mar 17.

11.

The search for novel analgesics: re-examining spinal cord circuits with new tools.

Smith KM, Madden JF, Callister RJ, Hughes DI, Graham BA.

Front Pharmacol. 2014 Feb 25;5:22. doi: 10.3389/fphar.2014.00022. eCollection 2014.

12.

Small renal mass biopsy--how, what and when: report from an international consensus panel.

Tsivian M, Rampersaud EN Jr, del Pilar Laguna Pes M, Joniau S, Leveillee RJ, Shingleton WB, Aron M, Kim CY, DeMarzo AM, Desai MM, Meler JD, Donovan JF, Klingler HC, Sopko DR, Madden JF, Marberger M, Ferrandino MN, Polascik TJ.

BJU Int. 2014 Jun;113(6):854-63. doi: 10.1111/bju.12470. Epub 2014 Jan 17. Review.

13.

Bone marrow biopsy: RNA isolation with expression profiling in men with metastatic castration-resistant prostate cancer--factors affecting diagnostic success.

Spritzer CE, Afonso PD, Vinson EN, Turnbull JD, Morris KK, Foye A, Madden JF, Roy Choudhury K, Febbo PG, George DJ.

Radiology. 2013 Dec;269(3):816-23. doi: 10.1148/radiol.13121782. Epub 2013 Oct 28.

14.

Appropriate and safe utilization of helicopter emergency medical services: a joint position statement with resource document.

Floccare DJ, Stuhlmiller DF, Braithwaite SA, Thomas SH, Madden JF, Hankins DG, Dhindsa H, Millin MG.

Prehosp Emerg Care. 2013 Oct-Dec;17(4):521-5. doi: 10.3109/10903127.2013.804139. Epub 2013 Jul 8.

PMID:
23834231
15.

Development and clinical validation of a real-time PCR assay for PITX2 DNA methylation to predict prostate-specific antigen recurrence in prostate cancer patients following radical prostatectomy.

Dietrich D, Hasinger O, Bañez LL, Sun L, van Leenders GJ, Wheeler TM, Bangma CH, Wernert N, Perner S, Freedland SJ, Corman JM, Ittmann MM, Lark AL, Madden JF, Hartmann A, Schatz P, Kristiansen G.

J Mol Diagn. 2013 Mar;15(2):270-9. doi: 10.1016/j.jmoldx.2012.11.002. Epub 2012 Dec 22.

16.

Increasing dwell time of mitomycin C in the upper tract with a reverse thermosensitive polymer.

Wang AJ, Goldsmith ZG, Neisius A, Astroza GM, Oredein-McCoy O, Iqbal MW, Simmons WN, Madden JF, Preminger GM, Inman BA, Lipkin ME, Ferrandino MN.

J Endourol. 2013 Mar;27(3):288-93. doi: 10.1089/end.2012.0211. Epub 2012 Dec 6.

17.

Limitations on diversity in basic science departments.

Leboy PS, Madden JF.

DNA Cell Biol. 2012 Aug;31(8):1365-71. doi: 10.1089/dna.2012.1756. Epub 2012 Jul 9.

PMID:
22775445
18.

Apical surgical margins status in robot-assisted laparoscopic radical prostatectomy does not depend on disease characteristics.

Tsivian M, Zilberman DE, Ferrandino MN, Madden JF, Mouraviev V, Albala DM.

J Endourol. 2012 Apr;26(4):361-5. doi: 10.1089/end.2011.0336. Epub 2012 Jan 10.

PMID:
22192106
19.
20.

Clinical predictors of renal mass pathological features.

Tsivian M, Mouraviev V, Albala DM, Caso JR, Robertson CN, Madden JF, Polascik TJ.

BJU Int. 2011 Mar;107(5):735-740. doi: 10.1111/j.1464-410X.2010.09629.x. Epub 2010 Nov 5.

21.

Multicenter clinical validation of PITX2 methylation as a prostate specific antigen recurrence predictor in patients with post-radical prostatectomy prostate cancer.

Bañez LL, Sun L, van Leenders GJ, Wheeler TM, Bangma CH, Freedland SJ, Ittmann MM, Lark AL, Madden JF, Hartman A, Weiss G, Castaños-Vélez E.

J Urol. 2010 Jul;184(1):149-56. doi: 10.1016/j.juro.2010.03.012. Epub 2010 May 15.

PMID:
20478579
22.

Electronic pathology reporting: digitizing the College of American Pathologists cancer checklists.

de Baca ME, Madden JF, Kennedy M.

Arch Pathol Lab Med. 2010 May;134(5):663-4. doi: 10.1043/1543-2165-134.5.663. No abstract available.

PMID:
20441497
23.

Predicting occult multifocality of renal cell carcinoma.

Tsivian M, Moreira DM, Caso JR, Mouraviev V, Madden JF, Bratslavsky G, Robertson CN, Albala DM, Polascik TJ.

Eur Urol. 2010 Jul;58(1):118-26. doi: 10.1016/j.eururo.2010.03.011. Epub 2010 Mar 17.

PMID:
20346577
24.

111-In-capromab pendetide imaging using hybrid-γ camera-computer tomography technology is not reliable in detecting seminal vesicle invasion in patients with prostate cancer.

Tsivian M, Wright T, Price M, Mouraviev V, Madden JF, Kimura M, Wong T, Polascik TJ.

Urol Oncol. 2012 Mar-Apr;30(2):150-4. doi: 10.1016/j.urolonc.2009.12.005. Epub 2010 Mar 2.

PMID:
20189846
25.

Utilization of (111)In-Capromab pendetide SPECT-CT for detecting seminal vesicle invasion with recurrent prostate cancer after primary in situ therapy.

Kimura M, Tsivian M, Mouraviev V, Mayes JM, Price MM, Bannister MC, Madden JF, Wong TZ, Polascik TJ.

Int J Urol. 2009 Dec;16(12):971-5. doi: 10.1111/j.1442-2042.2009.02413.x.

26.

Changes in Gleason score grading and their effect in predicting outcome after radical prostatectomy.

Tsivian M, Sun L, Mouraviev V, Madden JF, Mayes JM, Moul JW, Polascik TJ.

Urology. 2009 Nov;74(5):1090-3. doi: 10.1016/j.urology.2009.03.043. Epub 2009 Jul 18.

PMID:
19616835
27.

Use of 111in-capromab pendetide immunoscintigraphy to image localized prostate cancer foci within the prostate gland.

Mouraviev V, Madden JF, Broadwater G, Mayes JM, Burchette JL, Schneider F, Smith J, Tsivian M, Wong T, Polascik TJ.

J Urol. 2009 Sep;182(3):938-47. doi: 10.1016/j.juro.2009.05.047. Epub 2009 Jul 17.

PMID:
19616259
28.

Can the conventional sextant prostate biopsy accurately predict unilateral prostate cancer in low-risk, localized, prostate cancer?

Mayes JM, Mouraviev V, Sun L, Tsivian M, Madden JF, Polascik TJ.

Urol Oncol. 2011 Mar-Apr;29(2):166-70. doi: 10.1016/j.urolonc.2009.03.011. Epub 2009 May 17.

PMID:
19451000
29.

Utility of a 3-dimensional transrectal ultrasound-guided prostate biopsy system for prostate cancer detection.

Chen VH, Mouraviev V, Mayes JM, Sun L, Madden JF, Moul JW, Polascik TJ.

Technol Cancer Res Treat. 2009 Apr;8(2):99-104.

PMID:
19334790
30.

Patient selection for hemiablative focal therapy of prostate cancer: variables predictive of tumor unilaterality based upon radical prostatectomy.

Polascik TJ, Mayes JM, Schroeck FR, Sun L, Madden JF, Moul JW, Mouraviev V.

Cancer. 2009 May 15;115(10):2104-10. doi: 10.1002/cncr.24258.

31.

Focal therapy for prostate cancer: pathologic basis.

Mouraviev V, Madden JF.

Curr Opin Urol. 2009 Mar;19(2):161-7. doi: 10.1097/MOU.0b013e328323f62b. Review.

PMID:
19188770
32.

Flaxseed supplementation (not dietary fat restriction) reduces prostate cancer proliferation rates in men presurgery.

Demark-Wahnefried W, Polascik TJ, George SL, Switzer BR, Madden JF, Ruffin MT 4th, Snyder DC, Owzar K, Hars V, Albala DM, Walther PJ, Robertson CN, Moul JW, Dunn BK, Brenner D, Minasian L, Stella P, Vollmer RT.

Cancer Epidemiol Biomarkers Prev. 2008 Dec;17(12):3577-87. doi: 10.1158/1055-9965.EPI-08-0008.

33.

The effect of cryoablation on the histologic interpretation of intraoperative biopsy of small clear cell renal carcinoma and renal oncocytoma.

Chen VH, Mayes JM, Madden JF, Stein AJ, Mouraviev V, Polascik TJ.

J Endourol. 2008 Aug;22(8):1617-21. doi: 10.1089/end.2008.0156.

PMID:
18620504
34.

Overcoming challenges in designing and implementing a phase II randomized controlled trial using a presurgical model to test a dietary intervention in prostate cancer.

Demark-Wahnefried W, George SL, Switzer BR, Snyder DC, Madden JF, Polascik TJ, Ruffin MT 4th, Vollmer RT.

Clin Trials. 2008;5(3):262-72. doi: 10.1177/1740774508091676.

35.

Pathologic stage T2a and T2b prostate cancer in the recent prostate-specific antigen era: implications for unilateral ablative therapy.

Polascik TJ, Mayes JM, Sun L, Madden JF, Moul JW, Mouraviev V.

Prostate. 2008 Sep 15;68(13):1380-6. doi: 10.1002/pros.20804.

PMID:
18543281
36.

WITHDRAWN: Can the conventional sextant prostate biopsy reliably diagnose unilateral prostate cancer in low-risk, localized, prostate cancer?

Mayes JM, Mouraviev V, Sun L, Madden JF, Polascik TJ.

Prostate Cancer Prostatic Dis. 2008 May 13. [Epub ahead of print]

PMID:
18475285
37.

Significant discrepancies between diagnostic and pathologic Gleason sums in prostate cancer: the predictive role of age and prostate-specific antigen.

Isariyawongse BK, Sun L, Bañez LL, Robertson C, Polascik TJ, Maloney K, Donatucci C, Albala D, Mouraviev V, Madden JF, Moul JW.

Urology. 2008 Oct;72(4):882-6. doi: 10.1016/j.urology.2008.02.021. Epub 2008 Apr 2.

PMID:
18384857
38.

Prostate cancer laterality does not predict prostate-specific antigen recurrence after radical prostatectomy.

Mouraviev V, Sun L, Madden JF, Mayes JM, Moul JW, Polascik TJ.

Urology. 2007 Dec;70(6):1141-5.

PMID:
18158035
39.

Preoperative radiotherapy and bevacizumab for angiosarcoma of the head and neck: two case studies.

Koontz BF, Miles EF, Rubio MA, Madden JF, Fisher SR, Scher RL, Brizel DM.

Head Neck. 2008 Feb;30(2):262-6.

PMID:
17685450
40.

Prostate cancer laterality as a rationale of focal ablative therapy for the treatment of clinically localized prostate cancer.

Mouraviev V, Mayes JM, Sun L, Madden JF, Moul JW, Polascik TJ.

Cancer. 2007 Aug 15;110(4):906-10.

41.

Analysis of laterality and percentage of tumor involvement in 1386 prostatectomized specimens for selection of unilateral focal cryotherapy.

Mouraviev V, Mayes JM, Madden JF, Sun L, Polascik TJ.

Technol Cancer Res Treat. 2007 Apr;6(2):91-5.

PMID:
17375971
42.

Malignant cystic nephroma.

Raj GV, Yowell C, Madden JF, Nosnik I, Mouraviev V, Polascik TJ.

Can J Urol. 2006 Dec;13(6):3348-50. Review.

PMID:
17187700
43.

Apical soft tissue biopsies predict biochemical failure in radical perineal prostatectomy patients with apical cancer involvement.

Kübler HR, Szukala SA, Madden JF, Tseng TY, Paulson DF, Vieweg J, Dahm P.

Prostate Cancer Prostatic Dis. 2007;10(1):72-6. Epub 2006 Dec 19.

PMID:
17179978
44.

A role for the G12 family of heterotrimeric G proteins in prostate cancer invasion.

Kelly P, Stemmle LN, Madden JF, Fields TA, Daaka Y, Casey PJ.

J Biol Chem. 2006 Sep 8;281(36):26483-90. Epub 2006 Jun 20.

45.

Anterior rectal wall gastrointestinal stromal tumor presenting clinically as prostatic mass.

Madden JF, Burchette JL, Raj GV, Daly JT, Tannenbaum M.

Urol Oncol. 2005 Jul-Aug;23(4):268-72.

PMID:
16018942
46.

Renal cryoablation and radio frequency ablation: an evaluation of worst case scenarios in a porcine model.

Brashears JH 3rd, Raj GV, Crisci A, Young MD, Dylewski D, Nelson R, Madden JF, Polascik TJ.

J Urol. 2005 Jun;173(6):2160-5.

PMID:
15879879
47.

Lysophosphatidic acid promotes survival of androgen-insensitive prostate cancer PC3 cells via activation of NF-kappaB.

Raj GV, Sekula JA, Guo R, Madden JF, Daaka Y.

Prostate. 2004 Oct 1;61(2):105-13.

PMID:
15305333
48.

Diagnostic impact of core-needle biopsy on fine-needle aspiration of non-Hodgkin lymphoma.

Gong JZ, Snyder MJ, Lagoo AS, Vollmer RT, Dash RR, Madden JF, Buckley PJ, Jones CK.

Diagn Cytopathol. 2004 Jul;31(1):23-30.

PMID:
15236260
49.

Pathology of parainfluenza virus infection in patients with congenital immunodeficiency syndromes.

Madden JF, Burchette JL Jr, Hale LP.

Hum Pathol. 2004 May;35(5):594-603.

PMID:
15138935
50.

Liposarcoma presenting as an intraluminal ureteral mass.

Raj GV, Madden JF, Anderson EE.

Urology. 2003 May;61(5):1035.

PMID:
12736039

Supplemental Content

Loading ...
Support Center